Thursday brought a muted day for the major index. The S&P 500 eked out a loss of just under 0.2%, settling at 769.79, while the tape beneath the surface told two wildly different stories: micro-cap specs trading like lottery tickets, and a handful of blue-chip heavyweights holding the line.
Market movers
|
S&P 500
769.79
-0.20%
|
Nasdaq 100
—
—
|
Dow Jones
—
—
|
Russell 2000
—
—
|
Volatility
—
—
|
| YXT | YXT.COM Group Holding Limited | 23.43 | +801.15% |
| INLF | INLIF Limited | 6.27 | +97.17% |
| ZYBT | Zhengye Biotechnology Holding Limited | 2.36 | +84.38% |
| RITR | Reitar Logtech Holdings Limited Ordinary shares | 0.26 | +79.33% |
| JLHL | Julong Holding Limited | 9.35 | +72.51% |
| RCON | Recon Technology, Ltd. | 0.06 | -84.53% |
| TDCL | GraniteShares 2x Long TDC Daily ETF | 12.79 | -48.61% |
| SUJA | Suja Life, Inc. | 6.14 | -46.18% |
| SXTC | China SXT Pharmaceuticals, Inc. | 0.07 | -45.57% |
| SPPL | Simpple Ltd. | 2.02 | -42.78% |
The gainers list reads like a penny-stock fever dream—YXT up 801%, INLF doubling, biotech and energy specs rallying hard—but these are rounding errors in the broader market. The real concern is the losers: RCON cratering 85%, TDCL (a 2x long crude ETF) down nearly 49%, and a string of sub-dollar health-tech names getting demolished. When leverage and small-cap drama dominate the leaderboards, it's usually a sign the big money is treading water.
The Daily Dollar is auto-generated for informational and educational purposes only. Nothing here is financial advice, a recommendation to buy or sell, or a forecast. Markets are risky; do your own research.